RNA, 7SL, cytoplasmic 466, pseudogene (RN7SL466P)

The RNA, 7SL, cytoplasmic 466, pseudogene (RN7SL466P) is classified as a pseudogene derived from the 7SL RNA sequence, which normally forms the RNA component of the signal recognition particle (SRP)[1][6]. Pseudogenes of 7SL RNA arise from the reverse flow of genetic information from RNA back into DNA, resulting in truncated, non-functional copies dispersed across the genome, often incapable of transcription or translation[6]. RN7SL466P is not considered a functional receptor, enzyme, transporter, or any known therapeutic target. It does not encode protein, and there is no evidence of direct biological function, disease relevance, or drug interactions specific to this locus[1][6]. The canonical 7SL RNA plays an essential role as a structural and functional component of the SRP, involved in directing the subcellular localization of secretory and membrane proteins[3][5]. However, this does not apply to its pseudogenes, including RN7SL466P, which lack SRP function. Most 7SL pseudogenes (like RN7SL466P) are only referenced in genetic annotation and not in clinical, biochemical, or therapeutic contexts[1][6]. If your interest is in active 7SL RNA or SRP biology, you should seek information about the canonical 7SL RNA gene instead. Key notes: - RN7SL466P is a truncated, nonfunctional pseudogene and not a valid therapeutic target[1][6]. - There is no evidence for involvement in disease, function, drug interaction, or clinical biomarker utility. - The name and context suggest this is an automatically annotated genomic artifact, not a biological or pharmacological target.

Other names

RN7SL466PRNA, 7SL, cytoplasmic 466, pseudogene